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Abstract Protein tyrosine phosphatases (PTPs) are key 
regulators in a variety of signal transduction processes. However, 
substrates for most PTPs have not been determined. In a 
previous report, we demonstrated that in a transient expression 
system the intracellular phosphatases PTPs IB and TC 
preferentially dephosphorylated the precursor form of several 
receptor tyrosine kinases. In this paper we show that the 
dephosphorylation of kinase precursors is a specific feature of 
PTPs IB and TC that is not shared by two other intracellular 
PTPs, PTPH1 or SHP-1. By contrast, the receptor phosphatase 
PTPa preferentially dephosphorylated the p*-subunit of the 
insulin receptor localized on the cell surface. The insulin receptor 
was a better substrate for PTPa than for other receptor type 
PTPs. We conclude that the intracellular PTPs IB and TC 
regulate the autophosphorylation of receptor tyrosine kinases 
during their posttranslational processing while receptor type 
PTPs regulate the mature, cell surface localized receptor 
tyrosine kinases. 
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1. Introduction 
Identification of protein tyrosine phosphatase (PTP) sub-
strates is of major importance to define the physiological 
role of PTPs. In vitro, several substrates of PTPs have been 
used to study target recognition and regulation of the catalytic 
activity, however, the results may depend on the specific sub-
strates and assay conditions [1]. On the other hand, overex-
pression of PTPs in cell lines can be toxic [2] or may lead to a 
shift in the expression pattern of seemingly unrelated TKs or 
PTPs [3]. Nevertheless, together with in vitro binding studies 
this approach has allowed the identification of SH2 domain 
binding partners and substrates for the tyrosine phosphatases 
SHP-1 and SHP-2 [4-6]. The results obtained could be con-
firmed with mouse strains carrying SHP-1 mutant genes [7]. 
Overexpression of the receptor type PTPa in embryonic car-
cinoma cells activates the cytoplasmic tyrosine kinase src by 
dephosphorylating the inhibiting carboxy-terminal tyrosine 
[8]. Similarly, dephosphorylation of the carboxy-terminal ty-
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rosine by PTP CD45 activates the Lck kinase and thereby the 
T-cell receptor complex. Only extracellular domain binding 
partners have been identified for other receptor type PTPs. 
PTPu, interacts in a homophilic manner with the PTPjj. extra-
cellular domain present on neighbouring cells, and the extra-
cellular part of PTP(3 binds to the GPI anchored protein con-
tactin on neuronal cells [9-11]. Intracellular substrates for 
these phosphatases have not been identified. 
For the intracellular PTPs IB and TC which have been 
found to associate by their carboxy-terminal amino acids 
with the endoplasmic reticulum (ER) no specific substrates 
have been found [12,13]. We have previously shown that lo-
calization to the ER confines the activity of PTPs IB and TC 
towards phosphotyrosine residues on receptor tyrosine kinases 
(RTKs) that share this intracellular compartment while being 
processed whereas the mature receptors are no targets for 
both PTPs [14]. This observation implies that PTPs IB and 
TC are capable of dephosphorylating phosphotyrosine resi-
dues within different amino acid sequences which is supported 
by in vitro assays and crystallization studies that show an 
easily accessible catalytic center of PTP IB [15]. We have fur-
thermore investigated the interaction of receptor tyrosine kin-
ases with CD45. The capability of CD45 to dephosphorylate 
RTKs was mainly confined to c-Kit and no discrimination 
was seen between the intracellular and the cell surface local-
ized receptor. In another study, we established a system that 
selected PTPs which negatively regulate the insulin receptor 
(IR) tyrosine kinase [16]. BHK cells overexpressing the IR did 
not grow and detached from the substratum when treated 
with insulin. Since overexpression of PTPa and to a lesser 
extent PTPs e and TC overcame this inhibiting effect we de-
cided to investigate the interaction of PTPa with the IR in 
more detail. In the present study, we compared the capability 
of the transmembrane PTPs a and £ and the intracellular 
PTPs IB and TC to dephosphorylate the IR upon transient 
expression in 293 cells or in BHK cell lines. We found that in 
contrast to these ER associated PTPs the transmembrane 
PTPs are highly specific for the cell surface localized form 
of the IR. 
2. Materials and methods 
2.1. DNAs, antibodies and cell lines 
All cDNAs were cloned into a cytomegalovirus early promoter 
based expression plasmid [17] and have been described earlier 
[14,16]. Polyclonal antisera were generated in rabbits using KLH 
coupled carboxy-terminal peptides of the IR, IGF-1R, PTPa and 
PTPE and an amino-terminal peptide for PTPs IB and TC. Mono-
clonal antibody 83-14, directed against the extracellular domain of the 
IR, has been described [18]. The generation of BHK cell lines over-
expressing the IR or the IR and PTPs a or TC has been described in 
[19]. 
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2.2. Transient expression experiments 
Experiments were performed as described [14]. Briefly, cells were 
grown in F12/DMEM, 50:50, with 10% fetal calf serum, 2 mM L-
glutamine, and antibiotics. 2 |j,g of plasmid DNA for receptor or 
phosphatase were transfected into 3 x10 s cells/10-cm2 well according 
to the protocol of Chen and Okayama [20]. 18 h after the addition of 
DNA precipitate, cells were washed once and supplied with fresh 
medium containing 0.5% serum. 24 h later, cells were stimulated 
with ligand (100 ng/ml; insulin or IGF-1) for 10 min and then lysed 
in 200 ul lysis buffer (50 mM HEPES, pH 7.2, 150 mM NaCl, 1.5 mM 
MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 2 mM phenyl-
methylsulfonyl fluoride, 10 ug/ml aprotinin, 100 mM NaF, 10 mM 
sodium pyrophosphate and 1 mM sodium orthovanadate). The lysate 
was centrifuged for 2 min at 12 500Xg, 30 ul of the supernatant 
taken, sample buffer added, proteins boiled for 10 min and analyzed 
by SDS-PAGE and immunoblotting. The cell surface localized frac-
tion of the IR was determined by incubation of the cells at 4°C for 30 
min and addition of 10 |Xg/ml of antibody 83-14 and 100 nM insulin. 
After incubation for an additional 1 h, the cells were washed 5 times 
with cold medium and lysed as described. 
3. Results 
In an earlier study we had suggested that the intracellular 
PTPs IB and TC preferentially dephosphorylate the precursor 
form of RTKs [14]. We hypothesized that transmembrane 
PTPs could exert their effects on the processed receptors lo-
calized at the cell surface and therefore compared the capacity 
of PTPs a and e and PTPs IB and TC to dephosphorylate the 
IR and the insulin-like growth factor 1 receptor (IGF-1 R) in 
293 cells transiently overexpressing these proteins. Equal 
amounts of IR expression plasmid were transfected either to-
gether with empty vector or with the respective PTP expres-
sion plasmid into 293 cells. The cells were made quiescent by 
incubation with medium containing 0.5% fetal calf serum, 
stimulated with insulin for 10 min and lysed in a Triton X-
100 containing lysis buffer. Aliquots of the lysates were com-
bined with Laemmli buffer, boiled for 5 min and proteins were 
separated by SDS-PAGE, transferred to nitrocellulose and 
incubated with phosphotyrosine specific antibody. After de-
tection of phosphorylated proteins, the antibody was stripped 
off the nitrocellulose and overexpression of proteins was veri-
fied by reblotting with protein specific antibodies (Fig. 1). IR 
and IGF-1 R assemble as 0^2 heterotetramers and, when 
overexpressed, the phosphorylated p-subunit (95 kDa) is de-
tected whereas the unphosphorylated extracellular a-subunit 
cannot be visualized. Autophosphorylated precursor forms 
with different degrees of glycosylation are detected at 170— 
180 kDa because the high expression level (up to 2X106 re-
ceptors per cell) overloaded the receptor processing system. 
Fig. 1. Coexpression of the IR or IGF-1 R with intracellular or 
transmembrane PTPs. Human embryonic kidney 293 cells transi-
ently overexpressing the indicated proteins were stimulated with in-
sulin for 10 min and lysed. Equal amounts of lysate were size sepa-
rated by electrophoresis, proteins transferred to nitrocellulose and 
blotted with phosphotyrosine antibody. IR, insulin receptor, IGF-
1R, insulin like growth factor receptor-1, TC-C, catalytically inac-
tive PTPTC. 
Cooverexpression of PTPTC abolished tyrosine phosphoryla-
tion of receptor precursor whereas the p-subunit was phos-
phorylated almost as strongly as in control cells. By contrast, 
coexpression of the IR/IGF-1R with PTPs a or e reduced 
tyrosine phosphorylation of the P-subunit to background lev-
els whereas phosphorylation of the precursors was only par-
tially reduced but occurred to a greater extent in PTPe over-
expressing cells. Coexpression of catalytically inactive PTPTC 
had no effect on receptor tyrosine phosphorylation. 
Since dephosphorylation could also have been occurred 
while PTPa and the IR were processed and on their way to 
the cell surface, the degree of IR dephosphorylation at the cell 
surface was investigated more closely. Cells were transfected 
as in the previous experiment but before stimulation cooled to 
4°C to block receptor internalisation. Insulin was added as 
indicated, and all samples were incubated with monoclonal 
antibody 83-14 directed against the extracellular domain of 
the IR. After 1 h the cells were washed several times to re-
move unbound antibody, lysed, and the antibody-IR complex 
was collected with protein A Sepharose. Antibody 83-14 and 
protein A Sepharose were added to the supernatant to immu-
noprecipitate the residual IR. The phosphotyrosine content of 
the IR was detected by blotting with phosphotyrosine anti-
bodies. As shown in Fig. 2A, the P-subunit but not the pre-
cursor form is localized at the cell surface. Whereas coexpres-
sion of PTPa did reduce the phosphorylation of the P-subunit 
coexpression with PTPIB had no effect. Fig. 2B shows the 
phosphotyrosine content of the residual IR that is not local-
ized at the cell surface. The IR precursor is immunoprecipi-
tated with low efficiency but clearly dephosphorylation oc-
curred only when PTPIB was coexpressed. Phosphorylation 
Fig. 2. Interaction of the IR and PTPs in different cellular compartments. 293 cells transiently overexpressing the IR alone or together with 
PTPIB or PTPa were cooled to 4°C, incubated with monoclonal antibody 83-14 and insulin as indicated for 1 h, washed, lysed and the anti-
body-IR complex collected (A). IR remaining in the supernatant was immunoprecipitated with antibody 83-14 (B). An immunoblot with anti-
body directed against phosphotyrosine is shown. 
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Fig. 3. Effect of inhibition of glycosylation on IR dephosphoryla-
tion. 293 cells transiently overexpressing the IR alone or together 
with PTP1B or PTPoc were treated overnight with tunicamycin, 
stimulated with insulin for 10 min as indicated and lysed. The phos-
photyrosine content of the IR was analysed. 
of the P-subunit was insulin dependent but also found in un-
stimulated cells because of the high number of expressed re-
ceptors which leads to spontaneous kinase activation. This 
spontaneous activation was reduced when PTPs were coex-
pressed, as was the phosphorylation of the P-subunit in insulin 
stimulated cells. 
In a complementary approach we tested the effect of PTP 
cooverexpression on IR tyrosine phosphorylation in the pres-
ence of tunicamycin, an inhibitor of JV-glycosylation (Fig. 3). 
Treatment with 10 ug/ml tunicamycin overnight increased the 
amount of phosphorylated 170 kDa precursor whereas the 
amount of processed P-subunit decreased. PTPoc could not 
dephosphorylate the IR precursor but PTP IB dephosphoryl-
ated even the unglycosylated precursor form. 
A similar experiment was performed using BHK cells stably 
overexpressing 5x 106 IR or the IR and in addition PTPoc or 
PTPTC. As shown in the left part of Fig. 4A, in cells not 
treated with tunicamycin the main tyrosine phosphorylated 
protein was the IR P-subunit. Phosphorylation was clearly 
ligand dependent and reduced when PTPoc or PTPTC were 
coexpressed. Since the amount of IR in these cell lines varies 
slightly the reduction of P-subunit phosphorylation does not 
reflect the activity of the coexpressed phosphatase (Fig. 4B). 
The 170 kDa phosphoprotein in cells not treated with tunica-
mycin probably represents IRS-1 since it was not detected by 
reblotting with IR specific antibodies. After treatment with 
tunicamyin a strongly phosphorylated protein appeared inde-
pendent of insulin stimulation that migrated at the same po-
sition as the IR precursor. Because ^-glycosylation was in-
hibited this precursor migrated faster than in untreated cells 
(Fig. 4B). As predicted from the transient expression experi-
ments, however, the precursor was not phosphorylated in the 
presence of PTPTC. 
To evaluate the specificity of PTPoc or PTP IB activity in the 
transient expression system we coexpressed the insulin recep-
tor substrate-1 (IRS-1) and other PTPs together with the IR 
as shown in Fig. 5. PTPs CD45 and LAR are representatives 
of the family of transmembrane PTPs while PTPH1 and SHP-
1 are found intracellularly. None of these PTPs was able to 
dephosphorylate significantly the IRS-1, the IR precursor or 
the P-subunit although the total phosphotyrosine content of 
proteins was reduced, probably because some unspecific local-
ization of PTPs occurred. These results confirm our data ob-
tained in BHK-IR cells [19] and support the hypothesis that 
transmembrane PTPs are regulating RTKs localized at the cell 
surface while PTPs IB and TC are responsible for controlling 
the tyrosine phosphorylation state of RTK precursors. 
4. Discussion 
In the present report, we have investigated in more detail 
findings from previous studies that suggested a general role 
for ER associated PTPs to keep RTKs quiescent during their 
posttranslational processing. Since PTPs a and e were found 
to act as negative regulators of the IR tyrosine kinase we 
compared the dephosphorylating activity of these PTPs to-
wards the IR with that of PTPs IB and TC. In total cellular 
lysates from 293 cells transiently overexpressing these proteins 
dephosphorylation of the coexpressed IR by PTPoc occurred 
preferentially at the processed P-subunit (Figs. 2 and 3). At 
the cell surface, only PTPoc but not PTP IB coexpression re-
duced phosphotyrosine content of the p-subunit. When coex-
pressing IR and PTPoc, dephosphorylation of the P-subunit 
was more efficient in total cell lysate than at the cell surface, 
indicating that PTPoc and the processed IR both segregate 
Fig. 4. Inhibition of glycosylation in IR overexpressing BHK cells. Confluent cells were made quiescent, treated with tunicamycin (right part) 
or not (left part), stimulated with insulin as indicated and lysed in Triton X-100 buffer. The phosphotyrosine content of the IR was detected 
by blotting with phosphotyrosine specific antibodies (A). Antibodies were then stripped off the filter and the IR detected by specific antibody 
(B). 
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min as indicated. Analysis of phosphotyrosine content of the pro-
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